These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10705187)

  • 1. The EMCDDA/Pompidou Group treatment demand indicator protocol: a European core item set for treatment monitoring and reporting.
    Simon R; Donmall M; Hartnoll R; Kokkevi A; Ouwehand AW; Stauffacher M; Vicente J
    Eur Addict Res; 1999 Dec; 5(4):197-207. PubMed ID: 10705187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pompidou Group treatment demand protocol: the first pan-European standard in the field.
    Stauffacher M; Kokkevi A
    Eur Addict Res; 1999 Dec; 5(4):191-6. PubMed ID: 10705186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries.
    Montanari L; Pirona A; Guarita B; Hedrich D; Mounteney J; Vicente J
    J Stud Alcohol Drugs Suppl; 2019 Jan; Sup 18(18):139-151. PubMed ID: 30681958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addiction research centres and the nurturing of creativity. Monitoring the European drug situation: the ongoing challenge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
    Griffiths P; Mounteney J; Lopez D; Zobel F; Götz W
    Addiction; 2012 Feb; 107(2):254-8. PubMed ID: 21539630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The German monitoring and reporting system for the treatment of substance-related problems: a national system on the basis of aggregated data.
    Simon R; Hoch E; Holz A
    Eur Addict Res; 1999 Dec; 5(4):167-72. PubMed ID: 10705182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical perspectives in caring for people living with addictions: The European experience.
    Uchtenhagen AA
    Int Rev Psychiatry; 2010; 22(3):274-80. PubMed ID: 20528657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMCDDA Best Practice Promotion in Europe: an internet based dissemination tool.
    Ferri M; Bo A
    Adicciones; 2013; 25(1):3-6. PubMed ID: 23487273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring treatment demand for drug abuse in Spain: perspective over a decade.
    Alvarez-Requejo A; Suelves JM; Brugal MT; Correa JF
    Eur Addict Res; 1999 Dec; 5(4):179-84. PubMed ID: 10705184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of substance-related problems in Switzerland: implementing a new harmonised monitoring system.
    Maffli E; Schaaf S; Jordan MD; Güttinger F
    Int J Public Health; 2008; 53(1):31-9. PubMed ID: 18522367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of qualitative research on drug use in the European Union: report on an EMCDDA project. European Monitoring Centre for Drugs and Drug Addiction.
    Fountain J; Griffiths P
    Eur Addict Res; 1999 Mar; 5(1):4-20. PubMed ID: 10085497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug abuse monitoring: which pharmacoepidemiological resources at the European level?
    Lapeyre-Mestre M; Dupui M
    Therapie; 2015; 70(2):147-65. PubMed ID: 25858571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey measures demand for alcohol/drug rehab.
    Hospitals; 1991 Aug; 65(16):14. PubMed ID: 1651280
    [No Abstract]   [Full Text] [Related]  

  • 15. The Council of Europe Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (the Pompidou Group).
    Nagler NA
    Bull Narc; 1987; 39(1):31-40. PubMed ID: 3620762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the national addiction treatment infrastructure support the public's demand for quality care?
    McLellan AT; Carise D; Kleber HD
    J Subst Abuse Treat; 2003 Sep; 25(2):117-21. PubMed ID: 14680015
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug abuse: another challenge for the cardiologist?
    Anselmino M; Matta M; Gaita F
    J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):525-31. PubMed ID: 23857278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building a European consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction.
    Schaub MP; Uchtenhagen A;
    Eur Addict Res; 2013; 19(6):314-24. PubMed ID: 23774998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug misuse services. No quick fixes.
    Thomson R; Bellis M
    Health Serv J; 1997 Oct; 107(5576):30-1. PubMed ID: 10174936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.